Zhejiang DTRM Biopharma
4 clinical trials · Sponsor
◉ Watch Zhejiang DTRM Biopharma
| Record | Firm | Date |
|---|---|---|
| Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas (NCT04305444) | Zhejiang DTRM Biopharma | 2020-04-24 |
| BTK Inhibitor DTRMWXHS-12 in Mantle Cell Lymphoma (NCT03836768) | Zhejiang DTRM Biopharma | 2019-01-11 |
Track Zhejiang DTRM Biopharma automatically
Every clearance here is in the API, with alerts when new ones post.